| 4.72 -0.07 (-1.46%) | 01-13 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.62 |
1-year : | 5.87 |
| Resists | First : | 4.81 |
Second : | 5.03 |
| Pivot price | 4.79  |
|||
| Supports | First : | 4.47 |
Second : | 3.72 |
| MAs | MA(5) : | 4.86 |
MA(20) : | 4.73 |
| MA(100) : | 5.65 |
MA(250) : | 6.47 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 57.9 |
D(3) : | 72.3 |
| RSI | RSI(14): 44.5 |
|||
| 52-week | High : | 9.23 | Low : | 4.47 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AUNA ] has closed above bottom band by 38.0%. Bollinger Bands are 2.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.84 - 4.87 | 4.87 - 4.9 |
| Low: | 4.58 - 4.62 | 4.62 - 4.65 |
| Close: | 4.66 - 4.73 | 4.73 - 4.78 |
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
Tue, 13 Jan 2026
Travel Stocks: Why Auna SA stock remains on buy lists - 2025 Top Decliners & Comprehensive Market Scan Reports - moha.gov.vn
Fri, 09 Jan 2026
RWC Asset Management LLP Acquires Significant Stake in Auna SA - GuruFocus
Sat, 03 Jan 2026
Morgan Stanley Sees Growth Potential in Auna SA (AUNA) - Insider Monkey
Tue, 09 Dec 2025
Morgan Stanley lowers Auna SA stock price target to $10 from $11.50 - Investing.com
Thu, 04 Dec 2025
Stibbe advises Auna S.A. on its successful USD 765 million debt refinancing - Stibbe
Thu, 20 Nov 2025
Auna Announces 3Q25 Financial Results - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 30 (M) |
| Shares Float | 24 (M) |
| Held by Insiders | 21.1 (%) |
| Held by Institutions | 45.1 (%) |
| Shares Short | 286 (K) |
| Shares Short P.Month | 153 (K) |
| EPS | 0.98 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.51 |
| Profit Margin | 4.3 % |
| Operating Margin | 14.8 % |
| Return on Assets (ttm) | 5.8 % |
| Return on Equity (ttm) | 11.4 % |
| Qtrly Rev. Growth | -0.9 % |
| Gross Profit (p.s.) | 55.48 |
| Sales Per Share | 143.52 |
| EBITDA (p.s.) | 27.73 |
| Qtrly Earnings Growth | -51 % |
| Operating Cash Flow | 633 (M) |
| Levered Free Cash Flow | 137 (M) |
| PE Ratio | 4.81 |
| PEG Ratio | 0 |
| Price to Book value | 0.72 |
| Price to Sales | 0.03 |
| Price to Cash Flow | 0.22 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|